AKI Cardiosurgery Diagnostic Study (AKI-CDS)
Launched by UNIVERSITY OF ROSTOCK · Aug 14, 2018
Trial Information
Current as of July 22, 2025
Unknown status
Keywords
ClinConnect Summary
Acute kidney injury (AKI) is an abrupt loss of kidney function and occurs in up to 5-40% of patients who undergo cardiac surgery; dialysis being required in approximately 2-15% of all patients. AKI is a common problem in critically ill patients and is independently from underlying diseases associated with increased morbidity and mortality (to progressive loss of kidney function, cardiovascular disease, and death). Unfortunately, chronic kidney disease is often overlooked in its earliest, most treatable stages. Implementation of novel biomarkers into the clinical practice that reliably ident...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Female or male, at least 18 years old
- • Ability to consent to the study by patient or legal representative
- • Cardiac surgery with use of extracorporeal circulation (ECC)
- • Bypass (\> 2; ACB) or bypass + heart valve surgery
- • Two or three heart-valve operation
- Exclusion Criteria:
- • Dialysis-dependent patients with chronic, end-stage renal failure
- • Pre-existing renal replacement therapy
- • Infused prognosis (expected death in ≤ 12 hours despite maximal therapy)
- • Inability to consent of participation in the research project, of the patient or of the patients representative
- • Aortic surgery
- • Endocarditis
- • (Only) partial sternotomy (eg. aortic valve surgery)
About University Of Rostock
The University of Rostock is a prestigious academic institution located in Germany, dedicated to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university is committed to conducting innovative clinical trials that address pressing health challenges. Its research initiatives are supported by state-of-the-art facilities and a team of experienced professionals, enabling the exploration of cutting-edge therapies and interventions. The University of Rostock aims to contribute to the scientific community and improve patient outcomes through rigorous clinical investigation and the dissemination of knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rostock, , Germany
Patients applied
Trial Officials
Martin Sauer, MD
Principal Investigator
University Hospital of Rostock, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials